Order volume available up to 4 million tests per month, 48 million annually.

Xtrava_Health_Example_layout_cropped.png

The SPERA COVID-19 Ag Test

Fast. Reliable. Effective.

FDA EUA-Authorized, Xtrava Health’s SPERA™ COVID-19 Ag Test is a rapid lateral flow immunoassay detecting antigen from SARS-CoV-2 in shallow nasal samples authorized for use at the point of care. 

No training is required and users can expect sample collection to results within 15 minutes or less.

KEY HIGHLIGHTS

High Performing

92% sensitivity, 97% specificity

 

Effective Against Variants

Proven to detect all known variants including Delta and Lambda.

Fast

15 minutes results.

Long Self Life

12 month shelf life.

Efficient Packaging

10 tests per pack. 

Read More

High Capacity

Test capacity up to 4 million tests per month.

NIH Supported

Evaluated, funded and supported by the National Institutes of Health (NIH).

U.S Company

Silicon Valley based company with best-in-class manufacturing in Japan.

iStock-480473698.jpg

Accurate

More accurate than most rapid tests currently on the market, the SPERA™ COVID-19 Ag Test provides 92% sensitivity and 97% specificity.

RELIABLE

The SPERA™ COVID-19 Ag Test is top-ranked for its ease-of-use. 

The test is authorized for use in group settings such as schools, nursing homes, workplaces as well as doctor’s offices.

3b8f7a94808e44feae1d422322d70f92.webp
School-Nasal-boy.jpg

EFFICIENT

Multiple tests can be run in parallel without operating any complex and slow instruments.  

iStock-1266993065.jpg

Accurate and accessible testing. So we can get back to life’s simple pleasures.